Literature DB >> 713831

Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate.

G G Haddad, N M Mazza, R Defendini, W A Blanc, J M Driscoll, M A Epstein, R A Epstein, R B Mellins.   

Abstract

A new congenital syndrome characterized by the simultaneous failure of control of ventilation (Ondine's curse) and intestinal motility (Hirschsprung's disease) is reported in three infants, all of whom died in the first few months of life; two were siblings. Detailed studies in one also revealed markedly decreased esophageal motility and abnormal control of heart rate. In one infant, minute ventilation was lower in quiet than in REM sleep and lower in both states of sleep than in wakefulness. Although the mean inspiratory flow was decreased in quiet sleep, the hypoventilation resulted primarily from a decrease in respiratory frequency. Intravenous doxapram increased ventilation but did not reverse respiratory failure. Aminophyllin, progesterone, physostigmine and chlorpromazine did not change ventilation significantly; imipramine resulted in a significant decrease. Both long and short-term variability of the heart rate were markedly decreased when compared with the normal infant. Although neuropathologic studies postmorten did not reveal an anatomic defect, we postulate that a developmental abnormality in serotonergic neurons is responsible for this new syndrome.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 713831     DOI: 10.1097/00005792-197811000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  33 in total

Review 1.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Haddad syndrome--congenital central hypoventilation associated with Hirschsprung's disease.

Authors:  Susan D'Souza; R P Khubchandani
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

3.  Reduced caudate nuclei volumes in patients with congenital central hypoventilation syndrome.

Authors:  R Kumar; R Ahdout; P M Macey; M A Woo; C Avedissian; P M Thompson; R M Harper
Journal:  Neuroscience       Date:  2009-07-24       Impact factor: 3.590

4.  Novel neuropathologic findings in the Haddad syndrome.

Authors:  Nestor D Tomycz; Robin L Haynes; Edith F Schmidt; Kate Ackerson; Hannah C Kinney
Journal:  Acta Neuropathol       Date:  2009-10-21       Impact factor: 17.088

Review 5.  Hirschsprung's disease as a neurochristopathy.

Authors:  G Martucciello
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

6.  Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome.

Authors:  Rajesh Kumar; Paul M Macey; Mary A Woo; Jeffry R Alger; Ronald M Harper
Journal:  Pediatr Res       Date:  2008-09       Impact factor: 3.756

Review 7.  Congenital central hypoventilation syndrome and Hirschsprung's disease.

Authors:  G D Croaker; E Shi; E Simpson; T Cartmill; D T Cass
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

8.  Molecular analysis of congenital central hypoventilation syndrome.

Authors:  Ayako Sasaki; Masayo Kanai; Kazuki Kijima; Kazuhiro Akaba; Motoya Hashimoto; Hisaya Hasegawa; Shinsuke Otaki; Takenobu Koizumi; Satoshi Kusuda; Youhei Ogawa; Keiji Tuchiya; Wakako Yamamoto; Tomohiko Nakamura; Kiyoshi Hayasaka
Journal:  Hum Genet       Date:  2003-10-18       Impact factor: 4.132

Review 9.  Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature.

Authors:  A Verloes; C Elmer; D Lacombe; C Heinrichs; E Rebuffat; J L Demarquez; A Moncla; E Adam
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

10.  Hippocampal volume reduction in congenital central hypoventilation syndrome.

Authors:  Paul M Macey; Christopher A Richard; Rajesh Kumar; Mary A Woo; Jennifer A Ogren; Christina Avedissian; Paul M Thompson; Ronald M Harper
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.